<?xml version="1.0" encoding="UTF-8"?>
    <!DOCTYPE article PUBLIC "-//NLM/DTD JATS (Z39.96) Journal Publishing DTD v1.2 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
    <!--<?xml-stylesheet type="text/xsl" href="article.xsl">-->
<article xmlns:ns0="http://www.w3.org/1999/xlink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.2" xml:lang="en">
	<front>
		<journal-meta>
			<journal-id journal-id-type="issn">2303-9868</journal-id>
			<journal-id journal-id-type="eissn">2227-6017</journal-id>
			<journal-title-group>
				<journal-title>International Research Journal</journal-title>
			</journal-title-group>
			<issn pub-type="epub">2303-9868</issn>
			<publisher>
				<publisher-name>Cifra LLC</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.60797/IRJ.2025.162.79</article-id>
			<article-categories>
				<subj-group>
					<subject>Brief communication</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>SYNERGISTIC DETOXIFICATION OF AFLATOXIN M1 IN MILK USING CURCUMIN AND FERMENTATION-DERIVED MICROBIOTA</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author" corresp="yes">
					<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3303-7742</contrib-id>
					<name>
						<surname>Barua</surname>
						<given-names>Subhrajit</given-names>
					</name>
					<email>sbarua@itmo.ru</email>
					<xref ref-type="aff" rid="aff-1">1</xref>
				</contrib>
			</contrib-group>
			<aff id="aff-1">
				<institution-wrap>
					<institution-id institution-id-type="ROR">https://ror.org/04txgxn49</institution-id>
					<institution content-type="education">ITMO University</institution>
				</institution-wrap>
			</aff>
			<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2025-12-17">
				<day>17</day>
				<month>12</month>
				<year>2025</year>
			</pub-date>
			<pub-date pub-type="collection">
				<year>2025</year>
			</pub-date>
			<volume>6</volume>
			<issue>162</issue>
			<fpage>1</fpage>
			<lpage>6</lpage>
			<history>
				<date date-type="received" iso-8601-date="2025-11-25">
					<day>25</day>
					<month>11</month>
					<year>2025</year>
				</date>
				<date date-type="accepted" iso-8601-date="2025-12-09">
					<day>09</day>
					<month>12</month>
					<year>2025</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright: &amp;#x00A9; 2022 The Author(s)</copyright-statement>
				<copyright-year>2022</copyright-year>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
					<license-p>
						This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See 
						<uri xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</uri>
					</license-p>
					.
				</license>
			</permissions>
			<self-uri xlink:href="https://research-journal.org/archive/12-162-2025-december/10.60797/IRJ.2025.162.79"/>
			<abstract>
				<p>Aflatoxin M1 (AFM1) contamination in milk represents a critical food safety challenge due to its classification as a Group 1 human carcinogen by the IARC and its remarkable resilience to standard thermal processing methods, including pasteurization and UHT treatment. Traditional chemical decontamination strategies often compromise the sensory and nutritional integrity of dairy products. Consequently, there is an urgent industrial need for effective, non-destructive, and biologically safe mitigation strategies. This paper presents a theoretical synthesis and systematic review of two promising natural approaches: biological adsorption via fermentation-derived microorganisms (Lactic Acid Bacteria and yeasts) and chemical stabilization using curcuminoids.Data were aggregated from peer-reviewed studies indexed in Scopus, Web of Science, and RSCI (2010–2024). The analysis confirms that microbial sequestration is highly strain-specific. Lactobacillus rhamnosus and Saccharomyces boulardii demonstrate superior efficacy, with removal rates reaching 96.9% and 90.0% respectively under optimized conditions. However, a critical limitation identified across studies is the reversibility of the toxin-microbe complex; up to 60% of bound AFM1 can be released under the fluctuating pH conditions of the gastrointestinal tract, nullifying the detoxification benefit.To overcome this, we propose a novel synergistic detoxification model. Curcumin (diferuloylmethane) is identified as a complementary stabilizing agent. Its mechanism involves dual-phase activity: in vivo inhibition of the hepatic cytochrome P450 enzymes responsible for metabolizing Aflatoxin B1 into M1, and direct in vitro chemical quenching via hydrogen bonding and 𝜋-𝜋 stacking interactions. We hypothesize that the keto-enol tautomerism of curcumin in the acidic environment of fermented milk (pH 4.6) facilitates the formation of a stable &quot;supramolecular bridge&quot; between the AFM1 molecule and the bacterial cell wall peptidoglycans. This review outlines a theoretical framework for this combined approach, suggesting that curcumin-enhanced microbial binding could transform reversible adsorption into permanent sequestration, offering a robust safety solution for the global dairy industry.</p>
			</abstract>
			<kwd-group>
				<kwd>Aflatoxin M1</kwd>
				<kwd> curcumin</kwd>
				<kwd> Lactobacillus</kwd>
				<kwd> Saccharomyces</kwd>
				<kwd> milk safety</kwd>
				<kwd> synergistic detoxification</kwd>
				<kwd> food fermentations</kwd>
			</kwd-group>
		</article-meta>
	</front>
	<body>
		<sec>
			<title>HTML-content</title>
			<p>1. Introduction</p>
			<p>Aflatoxins, metabolites of Aspergillus molds, are highly regulated food contaminants. Aflatoxin M1 (AFM1) is the hydroxylated derivative of Aflatoxin B1 (AFB1), found primarily in milk and dairy products after contaminated feed consumption by lactating animals [2]. AFM1’s thermostability and prevalence necessitate effective decontamination methods that are non-destructive to milk’s nutritional profile [1].</p>
			<p>Traditional methods, such as chemical treatment or non-specific mineral adsorbents, often suffer from high cost or nutrient loss. Consequently, research has shifted toward biological interventions, specifically utilizing food-grade microorganisms like Lactic Acid Bacteria (LAB) and yeasts, and natural bioactive compounds like curcumin [6], [11]. While both strategies show promise independently, their combined potential for synergistic detoxification remains an underexplored critical research gap [10].</p>
			<p>2. Materials And Methods</p>
			<p>2.1. Information Retrieval Strategy</p>
			<p>The research methodology relied on a systematic review of peer-reviewed scientific publications indexed in major international and domestic bibliometric databases, including Scopus, Web of Science (WoS), and the Russian Science Citation Index (RSCI). The search strategy employed a combination of specific keywords and Boolean operators to identify relevant studies published primarily between 2010 and 2024. Key search terms included: &quot;Aflatoxin M1 detoxification,&quot; &quot;milk safety,&quot; &quot;probiotic adsorption,&quot; &quot;Lactobacillus binding efficiency,&quot; &quot;Saccharomyces,&quot; &quot;curcumin-mycotoxin interaction,&quot; and &quot;synergistic food preservation.&quot;</p>
			<p>2.2. Selection Criteria and Data Extraction</p>
			<p>To ensure the validity of the comparative analysis, specific inclusion and exclusion criteria were applied. The review prioritized: (a) experimental studies providing quantitative data on AFM1 reduction percentages in dairy matrices (milk, yogurt, cheese) or phosphate-buffered saline (PBS); (b) investigations utilizing food-grade microorganisms (GRAS status) suitable for fermentation; and (c) research elucidating the molecular mechanisms of adsorption (e.g., role of peptidoglycans and -glucans). Studies focusing solely on chemical reagents unrelated to food safety or non-consumable adsorbents were excluded. Data regarding strain specificity, binding capacity, and reversibility rates were extracted to compile the efficacy summary presented in Table 1.</p>
			<p>2.3. Theoretical Modeling Approach</p>
			<p>The conceptual model for synergistic detoxification was developed using a &quot;structure-function&quot; analytical approach. This involved cross-referencing the physical surface properties of selected microbial strains with the chemical reactivity profiles of curcuminoids. The synergy hypothesis was derived by analyzing the limitations of single-agent methods (specifically the reversibility of microbial binding) and theoretically mapping how curcumin’s chemical quenching capability could stabilize the toxin-microbe complex under physiological conditions.</p>
			<p>3. Microbial Biocontrol Mechanisms</p>
			<p>The primary biological mechanism for AFM1 reduction involves physical adsorption to the microbial cell wall, a non-covalent, rapid process [3], [4], [12].</p>
			<p>3.1. Efficacy and Key Strains</p>
			<p>Systematic reviews confirm the strong efficacy of probiotic strains against AFM1 in dairy systems [6], [11].</p>
			<p>● Lactic Acid Bacteria (LAB): Various strains, particularly those from the genus Lactobacillus, demonstrate high binding capacity. The average AFM1 removal efficiency in experimental models is 55.8%, with select strains achieving up to 96.9% reduction [6], [7]. Specific applications, such as the use of Lactobacillus rhamnosus LC-4 in yogurt, show reliable decontamination [14]. Furthermore, a Box-Behnken design study highlighted the high efficacy of combined L. rhamnosus and Saccharomyces cerevisiae strains [15].</p>
			<p>● Saccharomyces Yeasts: Yeasts show consistently high average efficacy, with Saccharomyces achieving an average reduction of 67.4% among tested genera [6]. Studies on strains like Saccharomyces boulardii confirm their high binding ability in reconstituted milk [7], [13].</p>
			<p>This superior efficacy is summarized in Table 1.</p>
			<table-wrap id="T1">
				<label>Table 1</label>
				<caption>
					<p>Efficacy Summary of Key AFM1 Detoxification Agents</p>
				</caption>
				<table>
					<tr>
						<td>Agent Type</td>
						<td>Example Strains</td>
						<td>Primary Mechanism</td>
						<td>Efficacy (Avg/Max Reduction)</td>
						<td>Reference</td>
					</tr>
					<tr>
						<td>Microbial Adsorption</td>
						<td> spp.</td>
						<td>Physical Binding (Peptidoglycans)</td>
						<td>Avg 55.8% / Max 96.9%</td>
						<td>[11]</td>
					</tr>
					<tr>
						<td>Microbial Adsorption</td>
						<td> spp.</td>
						<td>Physical Binding (β-glucans)</td>
						<td>Avg 67.4%</td>
						<td>[13]</td>
					</tr>
					<tr>
						<td>Chemical Stabilizer</td>
						<td>Curcumin</td>
						<td>Metabolic Inhibition / Chemical Quenching</td>
						<td> Detoxification</td>
						<td>[9]</td>
					</tr>
				</table>
			</table-wrap>
			<p>3.2. Limitations of Physical Adsorption</p>
			<p>The main limitation of microbial binding is the reversibility of the process. The non-covalent nature of the cell wall binding means that the AFM1-microbe complex can dissociate under the variable conditions (low pH, enzymatic activity) encountered in the gastrointestinal tract, potentially re-releasing the toxin [3]. However, specific strains, such as Lactobacillus rhamnosus GAF01, have been shown to maintain their protective ability in both in vitro binding assays and in vivo immunotoxicity models, suggesting strain selection is critical for overcoming reversibility [12].</p>
			<p>4. Curcumin As a Complementary Agent</p>
			<p>Curcumin, the primary polyphenol in turmeric, offers potent anti-carcinogenic and antioxidant properties that target aflatoxin toxicity through dual pathways. While its systemic action (in vivo Metabolic Inhibition) is crucial for general human health and prevention, the primary focus of the current synergistic model is on its direct in vitro activity within the milk matrix during the fermentation process. This direct action facilitates stable decontamination through the following mechanisms:</p>
			<p>1. Metabolic Inhibition (in vivo): Curcumin acts as a chemopreventative agent by modulating hepatic Phase I and Phase II enzymes. Studies show that curcuminoids can significantly reduce the excretion of AFM1 and other toxic metabolites in milk by inhibiting the conversion of AFB1 in the liver [8].</p>
			<p>2. Direct Binding (in vitro): Curcumin's chemical structure (specifically the β-diketone and phenolic groups) facilitates hydrogen bonding and π-π stacking interactions with mycotoxins [5]. Molecular simulations predict a strong affinity for the AFM1 molecule within the dairy matrix [9].</p>
			<p>5. Proposed Synergistic Detoxification Model</p>
			<p>Based on the synthesis of independent efficacy data, we propose a theoretical model for a &quot;Dual-Phase Synergistic System&quot; that integrates microbial adsorption with phytochemical stabilization.</p>
			<p>5.1. Mechanism of Interaction</p>
			<p>The proposed model addresses the primary weakness of microbial detoxification: weak non-covalent binding. In a standard fermentation system, AFM1 binds to the cell wall via van der Waals forces and weak hydrogen bonds, which are easily broken. We hypothesize that introducing stabilized curcumin creates a &quot;chemical anchor&quot; effect. Curcumin exists in equilibrium between keto and enol forms. In the acidic environment of fermented dairy (pH ~4.6), the enol form predominates, which effectively chelates divalent cations and forms strong hydrogen bonds.</p>
			<p>We postulate that curcumin molecules intercalate into the hydrophobic pockets of the bacterial cell wall (peptidoglycan layer in LAB; ꞵ-glucan layer in yeasts). When AFM1 encounters this modified surface, it interacts not only with the carbohydrate structure but also with the phenolic rings of the anchored curcumin. This effectively creates a ternary complex:</p>
			<p>[LATEX_FORMULA][Cell\; Wall] - [Curcumin] - [AFM1][/LATEX_FORMULA]</p>
			<p>5.2. Theoretical Validation (Figure 1 Description)</p>
			<fig id="F1">
				<label>Figure 1</label>
				<caption>
					<p>Theoretical AFM1 removal efficacy comparing standard microbial adsorption to the proposed synergistic model over the fermentation pH range (pH 6.8 to pH 4.2)</p>
				</caption>
				<alt-text>Theoretical AFM1 removal efficacy comparing standard microbial adsorption to the proposed synergistic model over the fermentation pH range (pH 6.8 to pH 4.2)</alt-text>
				<graphic ns0:href="/media/images/2025-12-11/bcafec57-ffbe-4dd4-aee5-576ba3380629.png"/>
			</fig>
			<p>The quantitative representation of the hypothesized synergistic advantage is detailed in the comparative simulation (see Fig. 1), which illustrates the theoretical AFM1 removal efficacy across the critical fermentation pH range (pH 6.8 to pH 4.2). The graph contrasts the performance of conventional microbial adsorption (dashed line, Control) with the predicted efficacy of the Synergistic Detoxification Model (solid line).In the control scenario, microbial efficacy, while strong, plateaus exhibit signs of destabilization below pH 5.5. This trend models the inherent reversibility limitation: the weak, non-covalent bonds holding the AFM1-microbe complex together begin to dissociate under increasing physiological stress and low pH conditions typical of the digestive system.</p>
			<p>Conversely, the proposed synergistic model demonstrates a critical and rapid divergence in removal efficiency, beginning around pH 5.2. This increase is directly correlated with the stabilization of the curcumin molecule into its enol tautomer, which maximizes the formation of the postulated chemical anchors (Section 5.1). This enhanced stabilization converts potentially reversible physical binding into a robust, high-affinity sequestration system, resulting in a sustained efficiency that approaches ~95% as the fermentation concludes. Figure 1 thus provides theoretical support for the hypothesis that the integration of a pH-sensitive phytochemical effectively mitigates the primary weakness of pure biological adsorption.</p>
			<p>5.3. Influence of Fermentation Parameters</p>
			<p>The synergy is dependent on pH. Curcumin is unstable at neutral pH but exhibits high stability under acidic conditions. Therefore, the lactic acid fermentation process serves a dual purpose: it lowers the pH to protect the curcumin molecule, which in turn protects the consumer by sequestering the aflatoxin. This mutual protection defines the novelty of the proposed method.</p>
			<p>5.4. Scope of Implementation and Technological Form</p>
			<p>The proposed synergistic model serves as a unified experimental hypothesis and a technological blueprint for functional dairy product development. Its immediate purpose is to guide future in vitro and in vivo studies designed to measure the efficiency of the ternary complex binding. The ultimate goal is its application as an industrial-scale strategy for producing functional fermented dairy products (e.g., yogurt or kefir) with certified, high-stability AFM1 decontamination</p>
			<p>5.5. Projected Quantitative Parameters for Synergy</p>
			<p>The synergistic effect is hypothesized to occur within specific quantitative ranges derived from established microbial and molecular studies [16], [17].</p>
			<p>● Microorganism Concentration: Optimal AFM1 adsorption is typically achieved at bacterial concentrations between  CFU/mL (Colony Forming Units per milliliter) in the dairy matrix. This high concentration range is naturally met during standard yogurt and kefir fermentation processes, and is confirmed by studies reporting peak AFM1 binding by various Lactobacillus strains at this cell density [16].</p>
			<p>● Curcumin Dosage: The projected effective concentration range for stabilized curcuminoids in the milk substrate should be between 5 and 20 µM (micromolar) to achieve chemical saturation of the available binding sites on the AFM1 molecules. This low micromolar range is supported by studies probing curcumin’s protective and binding effects in milk protein systems [17].</p>
			<p>● Time and pH Conditions: The formation of the stable ternary complex is maximized during the late exponential phase of fermentation (4 to 8 hours), as this phase correlates with the crucial pH drop from 6.8 (fresh milk) to 4.6 (final product), creating the optimal acidic environment for curcumin stabilization.</p>
			<p>5.6. Technological Feasibility and Organoleptic Profile</p>
			<p>A fundamental challenge for the industrial application of this synergistic system lies in the potential organoleptic consequences of curcumin's intense yellow color and characteristic earthy flavor [18]. To overcome this, the model requires the use of stabilized, flavor-neutral curcumin formulations (e.g., nanoemulsions or liposomal encapsulation) [19]. The use of curcumin nanoemulsions has been shown to avoid detrimental effects on the final product's color, taste, or texture, highlighting this as a technologically viable strategy to achieve the necessary low µM dosage while ensuring consumer acceptance [19].</p>
			<p>6. Conclusion</p>
			<p>Independent evidence confirms the high AFM1 removal efficiency of probiotic strains and the metabolic and chemical protective qualities of curcumin. Integrating these two natural, food-safe strategies, leveraging physical adsorption complemented by chemical stabilization, offers a compelling, novel direction for future research. Empirical validation of this synergistic model is urgently needed for industrial application in fermented dairy systems.</p>
		</sec>
		<sec sec-type="supplementary-material">
			<title>Additional File</title>
			<p>The additional file for this article can be found as follows:</p>
			<supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" id="S1" xlink:href="https://doi.org/10.5334/cpsy.78.s1">
				<!--[<inline-supplementary-material xlink:title="local_file" xlink:href="https://research-journal.org/media/articles/22548.docx">22548.docx</inline-supplementary-material>]-->
				<!--[<inline-supplementary-material xlink:title="local_file" xlink:href="https://research-journal.org/media/articles/22548.pdf">22548.pdf</inline-supplementary-material>]-->
				<label>Online Supplementary Material</label>
				<caption>
					<p>
						Further description of analytic pipeline and patient demographic information. DOI:
						<italic>
							<uri>https://doi.org/10.60797/IRJ.2025.162.79</uri>
						</italic>
					</p>
				</caption>
			</supplementary-material>
		</sec>
	</body>
	<back>
		<ack>
			<title>Acknowledgements</title>
			<p>Настоящая работа выполнена на Факультете биотехнологий Университета ИТМО. Автор выражает искреннюю благодарность своему научному руководителю, доктору Амину Мусави Ханега (Dr. Amin Mousavi Khaneghah), за его бесценное руководство, поддержку и научное наставничество в ходе данного исследования.</p>
		</ack>
		<sec>
			<title>Competing Interests</title>
			<p/>
		</sec>
		<ref-list>
			<ref id="B1">
				<label>1</label>
				<mixed-citation publication-type="confproc">Marchese S. Aflatoxin B1 and M1: Biological properties and their involvement in cancer development / S. Marchese [et al.].  // Toxins. — 2018. — Vol. 10. — № 6. — P. 214. — DOI: 10.3390/toxins10060214.</mixed-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation publication-type="confproc">Prandini A. On the occurrence of aflatoxin M1 in milk and dairy products / A. Prandini [et al.] // Food and Chemical Toxicology. — 2009. — Vol. 47. — № 5. — P. 984–991. — DOI: 10.1016/j.fct.2007.10.005.</mixed-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation publication-type="confproc">Haskard C.A. Surface binding of aflatoxin B1 by lactic acid bacteria / C. A. Haskard [et al.] // Applied and Environmental Microbiology. — 2001. — Vol. 67. — № 7. — P. 3086–3091. — DOI: 10.1128/AEM.67.7.3086-3091.2001.</mixed-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation publication-type="confproc">El-Nezami H. Adsorption of Mycotoxins by Probiotic Bacteria / H. El-Nezami [et al.] // International Journal of Food Microbiology. — 2004. — Vol. 91. — № 1. — P. 107–110. — DOI: 10.1016/j.ijfoodmicro.2003.07.005.</mixed-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation publication-type="confproc">Wang Y. Curcumin, a natural dietary component, as a potential inhibitor of aflatoxin B1 and M1 in food / Y. Wang, W. Zhang, J. Chen // Food Control. — 2021. — Vol. 125. — P. 107937. — DOI: 10.1016/j.foodcont.2021.107937.</mixed-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation publication-type="confproc">Monjazeb L. Biological Reduction of Aflatoxin M1 in Dairy Products Using Probiotic Strains: A Systematic Review and Meta-Analysis / L. Monjazeb Marvdashti [et al.] // World Mycotoxin Journal. — 2023. — Vol. 16. — № 3. — P. 239–250. — DOI: 10.1080/19390382.2023.2201490.</mixed-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation publication-type="confproc">Khadivi R. Aflatoxin M1-Binding Ability of Selected Lactic Acid Bacteria Strains and Saccharomyces boulardii in the Experimentally Contaminated Milk Treated with Some Biophysical Factors / R. Khadivi [et al.] // Archives of Razi Institute. — 2020. — Vol. 75. — № 1. — P. 63–73. — DOI: 10.22092/ari.2019.123985.1265.</mixed-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation publication-type="confproc">Girolami F. Effects of turmeric powder on aflatoxin M1 and aflatoxicol excretion in milk from dairy cows exposed to aflatoxin B1 at EU maximum tolerable levels / F. Girolami [et al.] // Toxins. — 2022. — Vol. 14. — № 7. — P. 430. — DOI: 10.3390/toxins14070430.</mixed-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation publication-type="confproc">Khadiv A. Molecular docking and dynamic simulation of curcumin interaction with aflatoxin M1 in dairy matrix / A. Khadiv, M. Sadeghi, A. Asoodeh // Journal of Molecular Structure. — 2024. — Vol. 1296. — P. 136709. — DOI: 10.1016/j.molstruc.2023.136709.</mixed-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation publication-type="confproc">Kolosova L.A. Perspektivy primeneniya prirodnyh adsorbentov i probiotikov dlya snizheniya urovnya aflatoksina M1 v molochnom syr'e [Prospects for the use of natural adsorbents and probiotics to reduce the level of aflatoxin M1 in raw milk] / L.A. Kolosova, V.I. Ganina, N.A. Ponomareva // Molochnaya Promyshlennost’ [Dairy Industry]. — 2024. — № 8. — P. 6–10. [in Russian]</mixed-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation publication-type="confproc">Zareie M. The Effect of Lactobacillus Strains on Aflatoxin M1 Residues in Dairy Products: A Systematic Review / M. Zareie, M. Sharifi, A. Abbasi // Food Science &amp;amp; Nutrition. — 2020. — Vol. 8. — № 9. — P. 4668–4679. — DOI: 10.1002/fsn3.1770.</mixed-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation publication-type="confproc">Abbès S. Ability of Lactobacillus rhamnosus GAF01 to remove AFM1 in vitro and to counteract AFM1 immunotoxicity in vivo / S. Abbès [et al.] // Journal of Immunotoxicology. — 2013. — Vol. 10. — № 3. — P. 273–281. — DOI: 10.3109/1547691X.2012.748689.</mixed-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation publication-type="confproc">Rezasoltani S. Detoxification of aflatoxin M1 by probiotics Saccharomyces boulardii, Lactobacillus casei, and Lactobacillus acidophilus in reconstituted milk / S. Rezasoltani [et al.] // Gastroenterology and Hepatology from Bed to Bench. — 2022. — Vol. 15. — № 3. — P. 224–230. — DOI: 10.22037/ghfbb.v15i3.2721.</mixed-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation publication-type="confproc">Zhang G. Decontamination of Aflatoxin M1 in Yogurt Using Lactobacillus rhamnosus LC-4 / G. Zhang [et al.] // Journal of Food Safety. — 2019. — Vol. 39. — № 1. — P. e12673. — DOI: 10.1111/jfs.12673.</mixed-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation publication-type="confproc">Salem-Bekhit M. Box–Behnken Design for Assessing the Efficiency of Aflatoxin M1 Detoxification in Milk Using Lactobacillus rhamnosus and Saccharomyces cerevisiae / M. Salem-Bekhit [et al.] // Life. — 2023. — Vol. 13. — № 1. — P. 168. — DOI: 10.3390/life13010168.</mixed-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation publication-type="confproc">Khadivi R. Aflatoxin M1-Binding Ability of Selected Lactic Acid Bacteria and the Stability of the Resulting Complexes in Milk / R. Khadivi [et al.] // Toxins. — 2020. — Vol. 12. — № 3. — P. 151. — DOI: 10.3390/toxins12030151.</mixed-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation publication-type="confproc">Mazaheri M. Curcumin Protects β-Lactoglobulin Fibril Formation and Fibril-Induced Cytotoxicity / M. Mazaheri [et al.] // PLOS ONE. — 2015. — Vol. 10. — № 7. — P. e0132386. — DOI: 10.1371/journal.pone.0132386.</mixed-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation publication-type="confproc">Sharifi-Rad J. Turmeric and Its Major Compound Curcumin on Health / J. Sharifi-Rad [et al.] // Molecules. — 2020. — Vol. 25. — № 19. — P. 4389. — DOI: 10.3390/molecules25194389.</mixed-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation publication-type="confproc">Bagale U. Prospect of Bioactive Curcumin Nanoemulsion as Effective Agency to Improve Milk Based Soft Cheese by Using Ultrasound Encapsulation Approach / U. Bagale [et al.] // Foods. — 2023. — Vol. 12. — № 3. — P. 600. — DOI: 10.3390/foods12030600.</mixed-citation>
			</ref>
		</ref-list>
	</back>
	<fundings/>
</article>